Metallothionein protein and mRNA in the toxic milk mouse

Tekijä Koropatnick, James, Cherian, M. George
Julkaistu 1994

Reduced CD5 on CD8(+) T Cells in Tumors but Not Lymphoid Organs Is Associated With Increased Activation and Effector Function

Tekijä Alotaibi, Faizah, Vincent, Mark, Min, Wei-Ping, Koropatnick, James
Julkaisussa Front Immunol (2021)

COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo

Tekijä Salim, Kowthar Y., Vareki, Saman Maleki, Danter, Wayne R., Koropatnick, James
Julkaisussa Oncotarget (2016)

Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines

Tekijä Maleki Vareki, Saman, Salim, Kowthar Y., Danter, Wayne R., Koropatnick, James
Julkaisussa PLoS One (2018)

Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells

Tekijä Ferguson, Peter J, DeMoor, Janice M, Vincent, Mark D, Koropatnick, James
Julkaistu 2001

Antisense Targeting of Thymidylate Synthase (TS) mRNA Increases TS Gene Transcription and TS Protein: Effects on Human Tumor Cell Sensitivity to TS Enzyme-Inhibiting Drugs

Tekijä Jason, Tracey L. H., Berg, Randal W., Vincent, Mark D., Koropatnick, James
Julkaisussa Gene Expr (2018)

Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined “Complementary Lethality”

Tekijä Rytelewski, Mateusz, Ferguson, Peter J, Vareki, Saman Maleki, Figueredo, Rene, Vincent, Mark, Koropatnick, James
Julkaistu 2013

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Tekijä Rytelewski, Mateusz, Buensuceso, Adrian, Leong, Hon S., Deroo, Bonnie J., Chambers, Ann F., Koropatnick, James
Julkaisussa J Vis Exp (2015)

Correction: COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo

Tekijä Salim, Kowthar Y., Vareki, Saman Maleki, Danter, Wayne R., San-Marina, Serban, Koropatnick, James
Julkaisussa Oncotarget (2017)

Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy

Tekijä Gameiro, Steven F., Ghasemi, Farhad, Barrett, John W., Koropatnick, James, Nichols, Anthony C., Mymryk, Joe S., Maleki Vareki, Saman
Julkaisussa Oncoimmunology (2018)

Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells

Tekijä Ferguson, Peter J, Collins, Olga, Dean, Nicholas M, DeMoor, Janice, Sha-Li, Chen, Vincent, Mark D, Koropatnick, James
Julkaistu 1999

Voluntary running exercise protects against sepsis-induced early inflammatory and pro-coagulant responses in aged mice

Tekijä Tyml, Karel, Swarbreck, Scott, Pape, Cynthia, Secor, Dan, Koropatnick, James, Feng, Qingping, Veldhuizen, Ruud A. W., Gill, Sean E.
Julkaisussa Crit Care (2017)

Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin

Tekijä Vareki, Saman Maleki, Rytelewski, Mateusz, Figueredo, Rene, Chen, Di, Ferguson, Peter J., Vincent, Mark, Min, Weiping, Zheng, Xiufen, Koropatnick, James
Julkaistu 2014

siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine

Tekijä Di Cresce, Christine, Figueredo, Rene, Rytelewski, Mateusz, Vareki, Saman Maleki, Way, Colin, Ferguson, Peter J., Vincent, Mark D., Koropatnick, James
Julkaisussa Oncotarget (2015)

IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells

Tekijä Maleki Vareki, Saman, Chen, Di, Di Cresce, Christine, Ferguson, Peter J., Figueredo, Rene, Pampillo, Macarena, Rytelewski, Mateusz, Vincent, Mark, Min, Weiping, Zheng, Xiufen, Koropatnick, James
Julkaisussa PLoS One (2015)

THE HYALURONAN RECEPTORS CD44 AND RHAMM (CD168) FORM COMPLEXES WITH ERK1,2, WHICH SUSTAIN HIGH BASAL MOTILITY IN BREAST CANCER CELLS

Tekijä Hamilton, Sara R., Fard, Shireen F., Paiwand, Frouz F., Tolg, Cornelia, Veiseh, Mandana, Wang, Chao, McCarthy, James B., Bissell, Mina J., Koropatnick, James, Turley, Eva A.
Julkaistu 2007

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy

Tekijä Wagner, Samuel C, Markosian, Boris, Ajili, Naseem, Dolan, Brandon R, Kim, Andy J, Alexandrescu, Doru T, Dasanu, Constantin A, Minev, Boris, Koropatnick, James, Marincola, Francesco M, Riordan, Neil H
Julkaistu 2014

miR-149-3p reverses CD8(+) T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cells

Tekijä Zhang, Meng, Gao, Dian, Shi, Yanmei, Wang, Yifan, Joshi, Rakesh, Yu, Qiongfang, Liu, Daheng, Alotaibi, Faizah, Zhang, Yujuan, Wang, Hongmei, Li, Qing, Zhang, Zhu-Xu, Koropatnick, James, Min, Weiping
Julkaisussa Open Biol (2019)

From Solo in the Silo to Strategic Training Programs

Tekijä Koritzinsky, Marianne, Koch, C. Anne, Riley, Barbara, Beauchemin, Nicole, Johnston, Gerry, Johnston, Michael, Koropatnick, James, Loiselle, Carmen G., Maslowska, Magdalena, McCormick, Craig, Miller, Wilson H., Mulligan, Lois, Tsao, Ming-Sound
Julkaisussa CBE Life Sci Educ (2016)

Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2

Tekijä Rytelewski, Mateusz, Vareki, Saman Maleki, Mangala, Lingegowda S., Romanow, Larissa, Jiang, Dahai, Pradeep, Sunila, Rodriguez-Aguayo, Christian, Lopez-Berestein, Gabriel, Figueredo, Rene, Ferguson, Peter J., Vincent, Mark, Sood, Anil K., Koropatnick, James D.
Julkaisussa Oncotarget (2016)